Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer

Jian Wang(Genesis Laboratories), S. Perwez Hussain(National Institutes of Health), Jochen Gaedcke(Universitätsmedizin Göttingen), Thomas Ried(National Institutes of Health), Matthias M. Gaida(Johannes Gutenberg University Mainz), Harris G. Yfantis(University of Maryland, Baltimore), Nader Hanna(University of Maryland, Baltimore), B. Michael Ghadimi(Universitätsmedizin Göttingen), Aaron J. Schetter(AstraZeneca (Singapore)), Dong Ho Lee(Seoul National University Hospital), Peijun He(University of Maryland, Baltimore), Shouhui Yang(National Institutes of Health), H. Richard Alexander(Umeå University)
Clinical Cancer Research
July 12, 2016
Cited by 68


Related Papers